Cytotoxic effects of ultra-diluted remedies on breast cancer cells

International Journal of Oncology

Volumn 36, Issue 2, 2010, Pages 395-403

  Frenkel, Moshe ^a   Mishra, Bal Mukund ^a   Sen, Subrata ^a   Yang, Peiying ^a   Pawlus, Alison ^a   Vence, Luis ^a   Leblanc, Aimee ^a   Cohen, Lorenzo ^a   Banerji, Pratip ^b,c   Banerji, Prasanta ^b,c  

^a UNIVERSITY OF TEXAS   (United States)

^b P Banerji Homeopathic Research Foundation   (India)

^c PBH Research Foundation   (India)

Author keywords

Alternative medicine; Apoptosis; Breast cancer; Breast cancer cells; Cancer care; Cell cycle; Complementary medicine; Homeopathy; Integrative medicine; Integrative oncology

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOSIN EXTRACT; CASPASE 7; CONIUM MACULATUM EXTRACT; NATURAL PRODUCT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHYTOLACCA DECANDRA EXTRACT; PLANT EXTRACT; PROTEIN P27; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN; THUJA EXTRACT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; BREAST ADENOCARCINOMA; BREAST EPITHELIUM; CANCER CELL CULTURE; CARCINOSIN; CELL CYCLE ARREST; CELL DEATH; CELL VIABILITY; CHROMATOGRAPHY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVATION; HOMEOPATHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDICINAL PLANT; PHYTOLACCA DODECANDRA; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; THUJA; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONIUM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HOMEOPATHY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INDIA; PHYTOLACCA; PHYTOTHERAPY; TELOMERE; THUJA;

EID: 75449107545     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000512     Document Type: Article

References (17)

1. Barnes P, Bloom B and Nahin R: Complementary and alternative medicine use among adults and children: United States, 2007. National Health Statistics Reports; no. 12 National Center for Health Statistics, Hyattsville, MD, 2008.
2. Johannessen H, von Bornemann Hjelmborg J, Pasquarelli E, Fiorentini G, Di Costanzos F and Miccinesi G: Prevalence in the use of complementary medicine among cancer patients in Tuscany, Italy. Tumori 94: 406-410, 2008.
3. Trager-Maury S, Tournigand C, Maindrault-Goebel F, Afchain P, de Gramont A, Garcia-Larnicol ML, Gervais H and Louvet C: Use of complementary medicine by cancer patients in a French oncology department. Bull Cancer 94: 1017-1025, 2007.
4. Banerji P and Campbell DR: Cancer patients treated with the Banerji protocols utilising homoeopathic medicine: A Best Case Series Program of the National Cancer Institute USA. Oncol Rep 20: 69-74, 2008.
5. Banerji P: P. Banerji Homeopathic Research Foundation (PBHRF) in Kolkata, India, 2008.
6. Pathak S, Multani AS and Banerji P: Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: a novel treatment for human brain cancer. Int J Oncol 23: 975-982, 2003.
7. Thangapazham RL, Gaddipati JP, Rajeshkumar NV, Sharma A, Singh AK, Ives JA, Maheshwari RK and Jonas WB: Homeopathic medicines do not alter growth and gene expression in prostate and breast cancer cells in vitro. Integr Cancer Ther 5: 356-361, 2006.
8. Sherr CJ and Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512, 1999.
9. Shapiro GI: Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol 24: 1770-1783, 2006.
10. Lee YM and Sicinski P: Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human. Cell Cycle 5: 2110-2114, 2006.
11. Spankuch B, Kurunci-Csacsko E, Kaufmann M and Strebhardt K: Rational combinations of siRNAs targeting Plk1 with breast cancer drugs. Oncogene 26: 5793-5807, 2007.
12. Schwartz GK and Shah MA: Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 23: 9408-9421, 2005.
13. Enders GH and Maude SL: Traffic safety for the cell: influence of cyclin-dependent kinase activity on genomic stability. Gene 371: 1-6, 2006.
14. Wang X, Gorospe M, Huang Y and Holbrook NJ: p27Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene 15: 2991-2997, 1997.
15. Pathak S, Multani AS, Narayan S, Kumar V and Newman RA: Anvirzel, an extract of Nerium oleander, induces cell death in human but not murine cancer cells. Anticancer Drugs 11: 455-463, 2000.
16. Roy S, Gu M, Ramasamy K, Singh RP, Agarwal C, Siriwardana S, Sclafani RA and Agarwal R: p21/Cip1 and p27/Kip1 are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer. Cancer Res 69: 1166-1173, 2009.
17. Singh RP and Agarwal R: Natural flavonoids targeting deregulated cell cycle progression in cancer cells. Curr Drug Targets 7: 345-354, 2006.